Currently, no Health Canada-approved generic versions of semaglutide exist and we cannot speculate on other manufacturers plans
However, the absence of statistically significant effects of GLP-1R agonists, with respect to at least one fibrosis stage histological improvement without worsening of NASH, could be the result of: (i) the insufficient duration of the current studies
This positions it as the logical next intervention for treatment-resistant obesity rather than simply an alternative to existing agents
Even in pilot scale, we also have production capability of 30g
Gut Fuel, a prebiotic fiber and polyphenol powdered blend, made up of baobab fruit pulp, acacia seyal gum, solnul resistant potato starch, oat bran and grape seed extract, is designed to blend into smoothies, sauces and yogurt without affecting the taste